Intravenous 3-day Helicobacter pylori eradication therapy is highly effective in patients with bleeding peptic ulcer;Alta eficacia erradicadora de la infección por Helicobacter pylori de una pauta terapéutica intravenosa de 3 días de duración en pacientes con úlcera péptica sangrante

Gastroenterologia y Hepatologia

Volumn 25, Issue 6, 2002, Pages 383-386

  Ruiz Gomez F A ^a   Sanchez Serrano F J ^a   Martinez Egea A ^a   Garcia del Castillo G ^a   Sanchez Cuenca J ^a   Coronas Planas, M ^a  

^a HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; METRONIDAZOLE; PANTOPRAZOLE; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; ANTIINFECTIVE AGENT; ANTIULCER AGENT; BENZIMIDAZOLE DERIVATIVE; DRUG DERIVATIVE; OMEPRAZOLE; SULFOXIDE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BREATH ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DUODENUM BLEEDING; DUODENUM ULCER; ERADICATION THERAPY; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; STOMACH HEMORRHAGE; STOMACH ULCER; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DRUG COMBINATION; EVALUATION; HELICOBACTER INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PEPTIC ULCER BLEEDING; STATISTICAL ANALYSIS; TIME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BENZIMIDAZOLES; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; DATA INTERPRETATION, STATISTICAL; DRUG THERAPY, COMBINATION; DUODENAL ULCER; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFUSIONS, INTRAVENOUS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; PEPTIC ULCER HEMORRHAGE; STOMACH ULCER; SULFOXIDES; TIME FACTORS;

EID: 0036022835     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0210-5705(02)70270-7     Document Type: Article

References (28)

1. Helicobacter pylori and acute bleeding peptic ulcer
2. Heavy bacterial loads of H. pylori mat precipitate bleeding peptic ulcers but not bleeding severity
3. Erradication of Helicobacter pylori reduces the rate of duodenal ulcer rebleeding: A long-term follow-up study
4. The effect of antibiotic therapy on bleeding from duodenal ulcer
5. One-week low dose triple therapy is effective in treating Helicobacter pylori-infected patients with bleeding peptic ulcers
6. Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: The prevalence of the infection, the efficacy of 3 triple therapies and the role of erradication in preventing a hemorrhagic recurrence
7. The role of Helicobacter pylori erradication in the management of acute bleeding peptic ulcer
8. Bleeding peptic ulcers: Audit of erradication treatment for H. pylori
9. Helicobacter pylori erradication reduces the rate of rebleeding in ulcer haemorrhage
10. Triple terapia intravenosa de 3 días en pacientes con hemorragia digestiva por úlcera péptica asociada a infección por H. pylori
11. Medium-term results of oral and intravenous omeprazole/amoxicillin Helicobacter pylori erradication therapy
12. Sucessful Helicobacter pylori erradication: A systemic effect of antibiotics?
13. Combined intravenous and oral omeprazole/amoxicillin therapy in patients with Helicobacter pylori-positive acute peptic ulcer bleeding
14. Prospective study on the influence of gastroduodenal ulcer hemorrhage on the diagnostic methods in Helicobacter pylori infection
15. Mucosal pharmacokinetics and pilot study of short course of parenteral imipenem in the erradication of Helicobacter pylori
16. Estimación del tamaño de la muestra en la investigación clínica y epidemiológica
17. Intravenous omeprazole/amoxicillin and omeprazole pre-treatment in Helicobacter pylori-positive acute peptide ulcer bleeding. A pilot study
18. Secretion of intravenously administered antibiotics in gastric juice: Implications for management of Helicobacter pylori
19. Effect of omeprazole on movement of intravenously administered metronidazole into gastric juice and its significance in treatment of Helicobacter pylori
20. A liquid chromatography assay for the study of serum and gastric juice metronidazole concentrations in the treatment of Helicobacter pylori
21. The effect of omeprazole on the pharmacokinetics of metronidazole and hydroxymetronidazole in human plasma, saliva and gastric juice
22. Effect of omeprazole on the distribution of metronidazole, amoxicillin and claritromycin in human gastric juice
23. Gastric diffusion of antibiotics used against Helicobacter pylori
24. Amoxycillin resistance is one reason for failure of amoxycillin-omeprazole treatment of Helicobacter pylori infection
25. Activities of beta-lactams and macrolides against Helicobacter pylori
26. False-negative biopsy urease test in bleeding ulcers cause by the buffering effects of blood
27. Comparison of invasive and non-invasive tests for detecting Helicobacter pylori infection in bleeding peptic ulcers
28. Current European concepts in the management of Helicobacter pylori infection. The Maastrich Consensus report